The dysregulation of MIRD-226 in various diseases makes it an attractive target for therapeutic intervention. Several strategies have been proposed to modulate MIRD-226 expression, including:
In terms of efficiency, the MIRD-226 has a high capacity factor, which measures the reactor's ability to operate at full power over a given period. The reactor's advanced fuel design and optimized core configuration also enable it to achieve high fuel efficiency, reducing the need for refueling and minimizing waste production. MIRD-226